Avoid Risks

Targeting 14 lifestyle factors may prevent up to 45% of dementia cases

Targeting 14 lifestyle factors may prevent up to 45% of dementia cases

We previously discussed findings from the 2020 Lancet Commission on Dementia Prevention, Intervention and Care, suggesting that fully addressing 12 lifestyle risk factors may prevent up to 40% of  dementia cases. In July 2024, the Lancet Commission added two new risk factors and reported that 45% of dementia cases could be prevented by fully addressing 14 lifestyle factors [1]. The risk factors worth addressing vary by life stage: early life (under 18 years old), midlife (18 to 65 years old), and late life (over 65 years old).

EARLY LIFE

Not completing secondary education 
Not attending secondary school increases your risk of dementia [1; 2]. Low educational attainment can make people more vulnerable to cognitive decline, because it results in less “cognitive reserve”, a reserve that helps maintain cognitive function despite brain aging and even pathology in some cases. In contrast, lifelong learning is associated with improved brain health, and higher levels of cognitive activity at mid- or late-life are linked to delayed onset of cognitive impairment [3]. Even in people with less education, cognitive stimulation at work is associated with lower dementia risk [4].

MIDLIFE

Hearing loss 
Many high-quality observational studies suggest an association between hearing loss and subsequent dementia [1]. Studies have found that with every 10-dB decrease in hearing ability, there is a 4 to 24% higher risk of dementia [5; 6]. It is possible that hearing loss promotes the development of dementia, or the changes dementia produces in the brain impairs hearing function, or both. Hearing loss may also lead to social isolation or depression, both of which are also associated with dementia risk (see below). The good news is hearing loss may be corrected with the use of hearing aids. A recent analysis of four studies reported that people with hearing loss who used hearing aids had a significantly lower risk of cognitive decline and dementia [7].

High LDL cholesterol
At the time of the previous Lancet Commission on dementia published in 2020, the evidence related to LDL cholesterol was inconclusive [8]. Since then, studies have reported that high LDL cholesterol in midlife is associated with a higher risk of dementia [1; 9]. Excess brain cholesterol is associated with increased risk of stroke and deposition of Alzheimer’s disease-related pathology (i.e., amyloid and tau). In contrast, people who took lipid-lowering drugs did not have an increased risk of dementia, emphasizing the importance of treating high LDL cholesterol, not just for cardiovascular health, but also for brain health. 

Depression 
People with depression have a higher risk of dementia than those without depression. Depression at all adult ages is associated with higher dementia risk, but the evidence is most clear for midlife depression [1]. Depression may heighten dementia risk by increasing stress hormones, decreasing levels of proteins that are good for brain cells, and shrinking the hippocampus, a brain region critical for forming memory [10; 11]. People who were treated for depression by medication, psychotherapy, or combination therapy were less likely to develop dementia than people with depression who received no treatment [12], highlighting the importance of treating depression.

Traumatic brain injury
Traumatic brain injury is caused by car/motorcycle/bicycle accidents, military incidents, boxing, other contact sports, and falls. Studies suggest that traumatic brain injury is associated with a higher dementia risk, possibly leading to earlier onset of dementia by two to three years than in people without traumatic brain injury [13]. To prevent traumatic brain injury, the Centers for Disease Control and Prevention recommend wearing a seat belt every time you are in a motor vehicle; wear a helmet or appropriate headgear when riding bikes, motorcycles, snowmobiles, horses, or skateboards, as well as when you skate, ski, snowboard, or play contact sports [14]. It is also important to maintain a safe environment to prevent falls.

Physical inactivity 
Being physically active at all ages is associated with better cognition and lower dementia risk [1; 15]. There are many ways that physical activity might benefit brain health. It reduces chronic inflammation, improves blood flow, increases the release of a protein that is very good for brain cells [16], and improves cardiovascular and metabolic health [17; 18]. The World Health Organization recommends that adults get 150 to 300 minutes of moderate-intensity aerobic physical activity (or 75 to 150 minutes of vigorous-intensity physical activity) every week, along with at least two days a week of muscle-strengthening activities [19].

Diabetes 
In the previous Lancet Commission on dementia in 2020, type 2 diabetes in late life was associated with a higher risk of dementia [8]. Newer evidence suggests that the age of onset makes a difference, with a midlife onset of type 2 diabetes being significantly associated with higher dementia risk, while late-life onset is not [1]. It is possible that the longer duration of illness and poorly controlled diabetes may increase the risk of dementia. Type 2 diabetes and dementia share some characteristics, such as impaired insulin signaling, altered brain metabolism, vascular complications, inflammation, and oxidative stress [20]. A healthy diet, exercise, and weight control are the first steps of diabetes management, followed by medication(s).

Smoking 
Cigarettes and cigarette smoke contain more than 4,700 chemical compounds, including some that are highly toxic [21]. Observational studies have shown that people who smoke are at a higher risk of developing all types of dementia and a much higher risk (up to 79%) for Alzheimer's disease, specifically [22]. New evidence suggests that midlife smoking appears to be a stronger risk factor for dementia than smoking in late life [1]. The good news is that quitting can reduce your risk of dementia, as some studies report no increased risk in former smokers [23; 24]. 

Hypertension 
Studies suggest that having hypertension (high blood pressure) in midlife increases the risk of both vascular dementia and Alzheimer's disease [1; 26]. The evidence is mixed in late-life as some people who develop dementia have lower blood pressure than people without dementia [1]. Several analyses of multiple clinical trials found that people who received blood pressure medication had a lower risk of dementia and higher cognitive function than those receiving placebo [27; 28]. Hypertension can be managed through diet, lifestyle changes, and medications.

Obesity 
People who are obese in midlife have an increased risk of dementia compared to those with healthy body weight [29]. In an analysis that included a total of over five million people across 16 studies, higher central obesity, measured by waist circumference or waist-to-hip ratio, was associated with a greater risk of cognitive impairment and dementia [30]. Obesity is more common in people who do not get enough physical activity and is associated with increased risk for diabetes and hypertension, all of which are linked with increased dementia risk (see above). A study in people with mild cognitive impairment reported that normal body mass index (BMI under 25), greater physical activity, and healthier diet were associated with lower levels of plaques and tangles, which are markers of Alzheimer’s disease [31].

Excessive alcohol consumption
Heavy drinking is associated with cognitive impairment and dementia [1]. The definition of heavy drinking varies across studies, but often refers to more than 21 units of alcohol per week (1 unit = 8 grams of pure alcohol; a single serving of wine or beer can have up to 3 units). In a longitudinal study that included over 31 million people hospitalized in France, alcohol use disorders (i.e., harmful use or dependence) were associated with a greater than 3-fold increased risk of dementia—and the increased risk was especially pronounced for earlier onset dementias with onsets before 65 years of age [32]. An analysis of 28 systematic reviews concluded that heavy alcohol use was associated with a higher risk of dementia and changes in brain structures [33]. 

LATE LIFE

Social isolation 
Social isolation is a risk factor not only for dementia but also for hypertension, coronary heart disease, and depression [2]. Low social participation, fewer social contacts, and more loneliness have all been associated with higher dementia risk [34]. Social isolation may result in decreased cognitive activity, which may accelerate cognitive decline and poor mood. Social contact in any form may reduce dementia risk by increasing cognitive reserve, brain volume, and healthy behaviors, and reducing stress and inflammation [35].

Air pollution
Many studies show that air pollution, often measured by PM2.5 (fine ambient particulate matters with diameters less than 2.5 microns) and PM10 (particles with diameters less than 10 microns), is a risk factor for dementia and cognitive impairment [1; 36; 37]. Although air pollution cannot be entirely avoided, there are steps you can take to reduce your exposure, such as monitoring air pollution levels online or with apps and stay indoors on days with particularly high air pollution. You can also limit exposure to car exhaust by closing vents and windows while in heavy traffic. 

Untreated visual loss
At the time of the previous Lancet Commission on dementia in 2020, vision loss was not considered as a risk factor for dementia [8]. However, new evidence has emerged since then. An analysis of numerous cohort studies reported that vision impairment is associated with a higher risk of both dementia and cognitive impairment [38]. These associations might be related to underlying illness, such as diabetes, which is a risk factor for both dementia and vision loss. A longitudinal cohort study in the US reported that people with cataract who had cataract extraction had a significantly lower dementia risk compared to those who did not have cataract extraction [39], highlighting the importance of treating vision impairment.

___

The Lancet report is great news in that there are concrete steps you can take to reduce dementia risk. Invest in lifelong learning and friendships, get enough physical activity, wear a seatbelt in motor vehicles (and proper head protection in contact sports), maintain a healthy weight, quit smoking, avoid excessive alcohol intake, and seek treatment for depression, hypertension, high LDL cholesterol, diabetes, hearing loss, and vision loss if you have these conditions. These recommendations are consistent with evidence from a seminal randomized controlled trial called FINGER that showed a group of lifestyle interventions that addressed many of these risk factors improved cognitive function in older people [40].

 

References:

  1. Livingston G, Huntley J, Liu KY et al. (2024) Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet.
  2. Livingston G, Sommerlad A, Orgeta V et al. (2017) Dementia prevention, intervention, and care. Lancet.
  3. Vemuri P, Lesnick TG, Przybelski SA et al. (2014) Association of lifetime intellectual enrichment with cognitive decline in the older population. JAMA Neurol  71, 1017-1024.
  4. Kivimaki M, Walker KA, Pentti J et al. (2021) Cognitive stimulation in the workplace, plasma proteins, and risk of dementia: three analyses of population cohort studies. Bmj  374, n1804.
  5. Yu RC, Proctor D, Soni J et al. (2024) Adult-onset hearing loss and incident cognitive impairment and dementia - A systematic review and meta-analysis of cohort studies. Ageing Res Rev  98, 102346.
  6. Lin FR, Metter EJ, O'Brien RJ et al. (2011) Hearing loss and incident dementia. Arch Neurol  68, 214-220.
  7. Yeo BSY, Song H, Toh EMS et al. (2023) Association of Hearing Aids and Cochlear Implants With Cognitive Decline and Dementia: A Systematic Review and Meta-analysis. JAMA Neurol  80, 134-141.
  8. Livingston G, Huntley J, Sommerlad A et al. (2020) Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet  396, 413-446.
  9. Wee J, Sukudom S, Bhat S et al. (2023) The relationship between midlife dyslipidemia and lifetime incidence of dementia: A systematic review and meta-analysis of cohort studies. Alzheimers Dement (Amst)  15, e12395.
  10. Lupien SJ, McEwen BS, Gunnar MR et al. (2009) Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci  10, 434-445.
  11. Geerlings MI, Gerritsen L (2017) Late-Life Depression, Hippocampal Volumes, and Hypothalamic-Pituitary-Adrenal Axis Regulation: A Systematic Review and Meta-analysis. Biol Psychiatry  82, 339-350.
  12. Yang L, Deng YT, Leng Y et al. (2023) Depression, Depression Treatments, and Risk of Incident Dementia: A Prospective Cohort Study of 354,313 Participants. Biol Psychiatry  93, 802-809.
  13. Schaffert J, LoBue C, White CL et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology  32, 410-416.
  14. CDC (2019) Traumatic Brain Injury & Concussion Prevention.
  15. Iso-Markku P, Kujala UM, Knittle K et al. (2022) Physical activity as a protective factor for dementia and Alzheimer's disease: systematic review, meta-analysis and quality assessment of cohort and case-control studies. British journal of sports medicine  56, 701-709.
  16. Jensen CS, Hasselbalch SG, Waldemar G et al. (2015) Biochemical Markers of Physical Exercise on Mild Cognitive Impairment and Dementia: Systematic Review and Perspectives. Front Neurol  6, 187.
  17. DeRight J, Jorgensen RS, Cabral MJ (2015) Composite cardiovascular risk scores and neuropsychological functioning: a meta-analytic review. Ann Behav Med  49, 344-357.
  18. Way KL, Hackett DA, Baker MK et al. (2016) The Effect of Regular Exercise on Insulin Sensitivity in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Diabetes Metab J  40, 253-271.
  19. WHO (2024) Physical activity
  20. Sebastiao I, Candeias E, Santos MS et al. (2014) Insulin as a Bridge between Type 2 Diabetes and Alzheimer Disease - How Anti-Diabetics Could be a Solution for Dementia. Front Endocrinol (Lausanne)  5, 110.
  21. Swan GE, Lessov-Schlaggar CN (2007) The effects of tobacco smoke and nicotine on cognition and the brain. Neuropsychol Rev  17, 259-273.
  22. Barnes DE, Yaffe K (2011) The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol  10, 819-828.
  23. Raggi M, Dugravot A, Valeri L et al. (2022) Contribution of smoking towards the association between socioeconomic position and dementia: 32-year follow-up of the Whitehall II prospective cohort study. The Lancet regional health Europe  23, 100516.
  24. Jeong SM, Park J, Han K et al. (2023) Association of Changes in Smoking Intensity With Risk of Dementia in Korea. JAMA network open  6, e2251506.
  25. Di Bari M, Pahor M, Franse LV et al. (2001) Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial. Am J Epidemiol  153, 72-78.
  26. Roman GC, Nash DT, Fillit H (2012) Translating current knowledge into dementia prevention. Alzheimer Dis Assoc Disord  26, 295-299.
  27. Hughes D, Judge C, Murphy R et al. (2020) Association of Blood Pressure Lowering With Incident Dementia or Cognitive Impairment: A Systematic Review and Meta-analysis. Jama  323, 1934-1944.
  28. Peters R, Xu Y, Fitzgerald O et al. (2022) Blood pressure lowering and prevention of dementia: an individual patient data meta-analysis. European heart journal  43, 4980-4990.
  29. Albanese E, Launer LJ, Egger M et al. (2017) Body mass index in midlife and dementia: Systematic review and meta-regression analysis of 589,649 men and women followed in longitudinal studies. Alzheimers Dement (Amst)  8, 165-178.
  30. Tang X, Zhao W, Lu M et al. (2021) Relationship between Central Obesity and the incidence of Cognitive Impairment and Dementia from Cohort Studies Involving 5,060,687 Participants. Neurosci Biobehav Rev  130, 301-313.
  31. Merrill DA, Siddarth P, Raji CA et al. (2016) Modifiable Risk Factors and Brain Positron Emission Tomography Measures of Amyloid and Tau in Nondemented Adults with Memory Complaints. Am J Geriatr Psychiatry  24, 729-737.
  32. Schwarzinger M, Pollock BG, Hasan OSM et al. (2018) Contribution of alcohol use disorders to the burden of dementia in France 2008-13: a nationwide retrospective cohort study. The Lancet Public health  3, e124-e132.
  33. Rehm J, Hasan OSM, Black SE et al. (2019) Alcohol use and dementia: a systematic scoping review. Alzheimer's research & therapy  11, 1.
  34. Kuiper JS, Zuidersma M, Oude Voshaar RC et al. (2015) Social relationships and risk of dementia: A systematic review and meta-analysis of longitudinal cohort studies. Ageing Res Rev  22, 39-57.
  35. Sommerlad A, Kivimaki M, Larson EB et al. (2023) Social participation and risk of developing dementia. Nature aging  3, 532-545.
  36. Abolhasani E, Hachinski V, Ghazaleh N et al. (2023) Air Pollution and Incidence of Dementia: A Systematic Review and Meta-analysis. Neurology  100, e242-e254.
  37. Wilker EH, Osman M, Weisskopf MG (2023) Ambient air pollution and clinical dementia: systematic review and meta-analysis. Bmj  381, e071620.
  38. Shang X, Zhu Z, Wang W et al. (2021) The Association between Vision Impairment and Incidence of Dementia and Cognitive Impairment: A Systematic Review and Meta-analysis. Ophthalmology  128, 1135-1149.
  39. Lee CS, Gibbons LE, Lee AY et al. (2022) Association Between Cataract Extraction and Development of Dementia. JAMA internal medicine  182, 134-141.
  40. Solomon A, Turunen H, Ngandu T et al. (2018) Effect of the Apolipoprotein E Genotype on Cognitive Change During a Multidomain Lifestyle Intervention: A Subgroup Analysis of a Randomized Clinical Trial. JAMA Neurol.

Yuko Hara, PhD, is Director of Aging and Alzheimer's Prevention at the Alzheimer's Drug Discovery Foundation. Dr. Hara was previously an Assistant Professor in Neuroscience at the Icahn School of Medicine at Mount Sinai, where she remains an adjunct faculty member. Her research focused on brain aging, specifically how estrogens and reproductive aging influence the aging brain's synapses and mitochondria. She earned a doctorate in neurology and neuroscience at Weill Graduate School of Medical Sciences of Cornell University and a bachelor's degree in biology from Cornell University, with additional study at Keio University in Japan. Dr. Hara has authored numerous peer-reviewed publications, including articles in PNAS and Journal of Neuroscience.

Get the latest brain health news:

Subscribe